S
S

Dividends • SILO Pharma

SILO

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
11/14/2023
12/1/2023
0,35
Quarterly
8/14/2023
9/1/2023
0,3
Quarterly
5/12/2023
6/1/2023
0,3
Quarterly
2/14/2023
3/1/2023
0,3
Quarterly
11/14/2022
12/1/2022
0,3
Quarterly
8/12/2022
9/1/2022
0,28
Quarterly
5/13/2022
6/1/2022
0,28
Quarterly
2/14/2022
3/1/2022
0,28
Quarterly